Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II-III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas.
Yu Zhou
1
,
Jiang Wang
1
,
Zhanni Gu
1
,
Shuni Wang
1
,
Wei Zhu
1
,
José Luis Aceña
2, 3
,
Vadim A Soloshonok
2, 4
,
Kunisuke Izawa
5
,
Hong Liu
1
3
5
Hamari Chemicals
Ltd., 1-4-29 Kunijima, Higashi-Yodogawa-ku, Osaka, Japan 533-0024
|
Publication type: Journal Article
Publication date: 2016-01-12
scimago Q1
wos Q1
SJR: 16.455
CiteScore: 100.5
Impact factor: 55.8
ISSN: 00092665, 15206890
PubMed ID:
26756377
General Chemistry
Abstract
Compounds Currently in Phase II−III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas Yu Zhou,† Jiang Wang,† Zhanni Gu,† Shuni Wang,† Wei Zhu,† Jose ́ Luis Aceña,*,‡,§ Vadim A. Soloshonok,*,‡,∥ Kunisuke Izawa,* and Hong Liu*,† †Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China ‡Department of Organic Chemistry I, Faculty of Chemistry, University of the Basque Country UPV/EHU, Paseo Manuel Lardizab́al 3, 20018 San Sebastiań, Spain Department of Organic Chemistry, Autońoma University of Madrid, Cantoblanco, 28049 Madrid, Spain IKERBASQUE, Basque Foundation for Science, María Díaz de Haro 3, 48013 Bilbao, Spain Hamari Chemicals Ltd., 1-4-29 Kunijima, Higashi-Yodogawa-ku, Osaka, Japan 533-0024
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
50
100
150
200
250
|
|
|
Organic Letters
207 publications, 8.21%
|
|
|
Journal of Organic Chemistry
190 publications, 7.54%
|
|
|
Angewandte Chemie - International Edition
126 publications, 5%
|
|
|
Angewandte Chemie
126 publications, 5%
|
|
|
Organic and Biomolecular Chemistry
106 publications, 4.2%
|
|
|
European Journal of Organic Chemistry
105 publications, 4.17%
|
|
|
Advanced Synthesis and Catalysis
103 publications, 4.09%
|
|
|
Chemical Communications
98 publications, 3.89%
|
|
|
Organic Chemistry Frontiers
96 publications, 3.81%
|
|
|
Chemistry - A European Journal
94 publications, 3.73%
|
|
|
Journal of Fluorine Chemistry
92 publications, 3.65%
|
|
|
ACS Catalysis
52 publications, 2.06%
|
|
|
Journal of the American Chemical Society
49 publications, 1.94%
|
|
|
Molecules
43 publications, 1.71%
|
|
|
Asian Journal of Organic Chemistry
43 publications, 1.71%
|
|
|
Chemical Science
41 publications, 1.63%
|
|
|
Synthesis
39 publications, 1.55%
|
|
|
Tetrahedron Letters
38 publications, 1.51%
|
|
|
Beilstein Journal of Organic Chemistry
35 publications, 1.39%
|
|
|
Tetrahedron
27 publications, 1.07%
|
|
|
ChemistrySelect
25 publications, 0.99%
|
|
|
RSC Advances
24 publications, 0.95%
|
|
|
Green Chemistry
23 publications, 0.91%
|
|
|
Chinese Journal of Chemistry
22 publications, 0.87%
|
|
|
Chemical Record
21 publications, 0.83%
|
|
|
Chinese Chemical Letters
20 publications, 0.79%
|
|
|
Journal of Medicinal Chemistry
19 publications, 0.75%
|
|
|
Nature Communications
18 publications, 0.71%
|
|
|
Synlett
18 publications, 0.71%
|
|
|
50
100
150
200
250
|
Publishers
|
100
200
300
400
500
600
700
800
|
|
|
Wiley
764 publications, 30.31%
|
|
|
American Chemical Society (ACS)
629 publications, 24.95%
|
|
|
Royal Society of Chemistry (RSC)
445 publications, 17.65%
|
|
|
Elsevier
312 publications, 12.38%
|
|
|
Springer Nature
91 publications, 3.61%
|
|
|
MDPI
69 publications, 2.74%
|
|
|
Georg Thieme Verlag KG
58 publications, 2.3%
|
|
|
Beilstein-Institut
35 publications, 1.39%
|
|
|
Taylor & Francis
16 publications, 0.63%
|
|
|
Pleiades Publishing
14 publications, 0.56%
|
|
|
Bentham Science Publishers Ltd.
9 publications, 0.36%
|
|
|
Shanghai Institute of Organic Chemistry
9 publications, 0.36%
|
|
|
Oxford University Press
8 publications, 0.32%
|
|
|
Frontiers Media S.A.
6 publications, 0.24%
|
|
|
OOO Zhurnal "Mendeleevskie Soobshcheniya"
6 publications, 0.24%
|
|
|
American Association for the Advancement of Science (AAAS)
4 publications, 0.16%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
3 publications, 0.12%
|
|
|
Canadian Science Publishing
2 publications, 0.08%
|
|
|
The Electrochemical Society of Japan
2 publications, 0.08%
|
|
|
Pharmaceutical Society of Japan
2 publications, 0.08%
|
|
|
Akademizdatcenter Nauka
2 publications, 0.08%
|
|
|
The Society of Synthetic Organic Chemistry, Japan
2 publications, 0.08%
|
|
|
Akademiai Kiado
2 publications, 0.08%
|
|
|
King Saud University
2 publications, 0.08%
|
|
|
Cellule MathDoc/Centre Mersenne
2 publications, 0.08%
|
|
|
Scientific Research Publishing
2 publications, 0.08%
|
|
|
Science in China Press
2 publications, 0.08%
|
|
|
American Society for Pharmacology and Experimental Therapeutics
1 publication, 0.04%
|
|
|
CSIRO Publishing
1 publication, 0.04%
|
|
|
100
200
300
400
500
600
700
800
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
2.5k
Total citations:
2525
Citations from 2024:
566
(22.45%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Zhou Yu. et al. Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II-III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas. // Chemical Reviews. 2016. Vol. 116. No. 2. pp. 422-518.
GOST all authors (up to 50)
Copy
Zhou Yu., Wang J., Gu Z., Wang S., Zhu W., Aceña J. L., Soloshonok V. A., Izawa K., Liu H. Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II-III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas. // Chemical Reviews. 2016. Vol. 116. No. 2. pp. 422-518.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1021/acs.chemrev.5b00392
UR - https://doi.org/10.1021/acs.chemrev.5b00392
TI - Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II-III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas.
T2 - Chemical Reviews
AU - Zhou, Yu
AU - Wang, Jiang
AU - Gu, Zhanni
AU - Wang, Shuni
AU - Zhu, Wei
AU - Aceña, José Luis
AU - Soloshonok, Vadim A
AU - Izawa, Kunisuke
AU - Liu, Hong
PY - 2016
DA - 2016/01/12
PB - American Chemical Society (ACS)
SP - 422-518
IS - 2
VL - 116
PMID - 26756377
SN - 0009-2665
SN - 1520-6890
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2016_Zhou,
author = {Yu Zhou and Jiang Wang and Zhanni Gu and Shuni Wang and Wei Zhu and José Luis Aceña and Vadim A Soloshonok and Kunisuke Izawa and Hong Liu},
title = {Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II-III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas.},
journal = {Chemical Reviews},
year = {2016},
volume = {116},
publisher = {American Chemical Society (ACS)},
month = {jan},
url = {https://doi.org/10.1021/acs.chemrev.5b00392},
number = {2},
pages = {422--518},
doi = {10.1021/acs.chemrev.5b00392}
}
Cite this
MLA
Copy
Zhou, Yu., et al. “Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II-III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas..” Chemical Reviews, vol. 116, no. 2, Jan. 2016, pp. 422-518. https://doi.org/10.1021/acs.chemrev.5b00392.